Genesis 104
Genesis 104 is a medical device (FDA Class II; FDA product code QJQ, Cranial Electrotherapy Stimulator To Treat Insomnia And/Or Anxiety) made by Neurofield, Inc., cleared under FDA 510(k) K252951 on 31 Dec 2025 and listed in FDA GUDID since 7 May 2026 (UDI-DI 00860010064634), active as of 22 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number00860010064634 | Date7 May 2026 | StatusListed |
| United States | FDA 510(k)SESE | NumberK252951 | Date31 Dec 2025 | StatusActive |
Official records
- AccessGUDID record 00860010064634
- FDA 510(k) database K252951
From the FDA record
- Device description
- Genesis Sleep is a non-invasive transdermal neurostimulation device to treat chronic insomnia. The device utilizes a technology known as electrical vestibular nerve stimulation (VeNS). It is indicated for clinical- and home-use to treat chronic insomnia in adults aged 22 and older. It consists of a battery-powered device designed to transcutaneously deliver low-level electrical energy (up to 1 mA) to the skin behind the ears, over the mastoid processes. The delivery of this neurostimulation is through two single-use self-adhesive electrode pads. These pads are placed on the skin behind each ear (mastoid area). The intensity of the electric pulse can be adjusted up or down by the user. When turned on, the device delivers a small electrical impulse which stimulates the vestibular nerve. When the device is not being used, the battery can be charged using the charging station provided. Therefore, it is not physically possible to recharge the battery while the device is in use in stimulation mode. The Genesis Sleep device exerts its therapeutic effect through electrical stimulation of the vestibular nerves. Electrical vestibular nerve stimulation (VeNS) is a non-invasive therapeutic method that applies pulsed, alternating microcurrent transcutaneously to the vestibular nerves via stimulation pads. Genesis Sleep delivers this neurostimulation through two self-adhesive stimulation pads which are placed on the skin behind each ear (mastoid processes). When turned on, the device delivers a small electrical impulse which can be adjusted up or down by the user.
- MRI safety
- MR Unsafe
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- FDA 510(k) K252951 decided 31 Dec 2025 Active
- FDA GUDID UDI-DI 00860010064634 listed 7 May 2026 Listed
Timeline
- Cleared FDA 510(k) K252951
- Listed FDA GUDID 00860010064634
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Trade name
- Genesis
- Generic name
- Psychiatric/stress-therapy periauricular nerve transcutaneous electrical stimulation system
- Model / reference
- 104
- Primary DI / UDI-DI
- 00860010064634
- 510(k) Number
- FDA product code
- QJQ
- GMDN term
- Psychiatric/stress-therapy periauricular nerve transcutaneous electrical stimulation system
- Device class
- Class II
- Regulation number
- 882.5800
- GUDID distribution status
- In Commercial Distribution
- MRI safety
- MR Unsafe
Similar devices
Other devices filed under FDA product code QJQ (Cranial Electrotherapy Stimulator To Treat Insomnia And/Or Anxiety).
- NF-1 MINDPEACE by NEURO-FITNESS LLC
- NET-2000 MICROCURRENT STIMULATOR by Auri-Stem Medical, Inc.
- LISS CRANIAL STIMULATOR MODEL SBL201-M by Medical Consultants Intl., Ltd.
- Modius Stress by NEUROVALENS LIMITED
- Cervella by Innovative Neurological Devices, LLC
- LISS CRANIAL STIMULATOR MODEL SBL202-B by Medical Consultants Intl., Ltd.
- Transcranial Electrotherapy Stimulator-A, Model TESA-1 by Kalaco Scientific, Inc.
- Alpha-Stim CS by Electromedical Products, Inc.
- CES ULTRA by NEURO-FITNESS LLC
- LB-2000 CRANIAL ELECTROTHERAPY STIMULATOR by Life Balance Intl., Inc.